Advancing Standards in Regenerative Medicine Act
Last action on Mar 4, 2016Referred to the Subcommittee on Health.
Take Action
Summary
Advancing Standards in Regenerative Medicine Act
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to facilitate the establishment of a public-private Standards Coordinating Body in Regenerative Medicine and Advanced Therapies. The FDA must work with this body to develop standards to support the development and review of regenerative medicine products.Lifecycle of the Bill
No events recorded for this stage yet.
